Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38789

DIS3L Knockout HGC-27 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Stomach

  • Disease:

    Carcinoma

The DIS3L Knockout HEK293T Polyclonal Cells provide a CRISPR/Cas9-edited population of human embryonic kidney cells with targeted disruption of the DIS3L gene. DIS3L is a scaffold subunit of the RNA exosome, interacting with EXOSC2, EXOSC3, and the SKI complex to coordinate mRNA decay and surveillance pathways. Loss of DIS3L disrupts RNA exosome integrity, leading to accumulation of aberrant transcripts and altered gene expression. This polyclonal knockout model is ideal for studying RNA metabolism, exosome function, and cancer-related RNA processing defects. Applications include transcriptomic analysis by RNA-seq, target-specific validation via RT-qPCR and Northern blotting, and functional assays such as proliferation and apoptosis studies. For pricing and technical details, contact Ascent Research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HGC-27

    Sex of Donor

    Unknown

    Age

    Unknown

    Derived From Site

    Metastatic; Lymph node

    Gene Name

    DIS3L

    Gene Identifier

    NCBI Gene ID 115752

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

This product consists of a CRISPR/Cas9-edited polyclonal knockout population of HEK293T cells specifically targeting the DIS3L gene. The polyclonal format provides a heterogeneous pool of edited cells, enabling researchers to study the consequences of DIS3L loss in a representative cellular context without single-cell clonal isolation. The editing strategy disrupts the DIS3L locus, establishing a loss-of-function model suitable for functional genomics, RNA biology, and mechanistic investigations.

The HEK293T host cell line is derived from human embryonic kidney epithelial cells and is widely utilized in biomedical research for its robust protein expression, efficient viral production, and tractable growth characteristics. The cells stably express the SV40 large T antigen, which supports episomal replication of plasmids containing the SV40 origin. These attributes make HEK293T an ideal platform for exploring gene function in a human cell background, particularly for genes involved in fundamental processes such as RNA metabolism and gene regulation.

DIS3L encodes a catalytically inactive subunit of the RNA exosome complex, serving as a scaffold protein that organizes the core exosome structure and facilitates the recruitment of active exoribonucleases like DIS3 and DIS3L2. Functioning within multiple RNA decay pathways??including mRNA surveillance, nonsense-mediated decay, and AU-rich element (ARE)-mediated degradation??DIS3L interacts with EXOSC2, EXOSC3, and SKI complex subunits to regulate the turnover of specific mRNAs. Its activity is modulated by cellular stress signals and ARE-binding factors, and its disruption leads to accumulation of transcripts encoding cell cycle regulators and oncoproteins, thereby perturbing gene expression homeostasis.

In the HEK293T context, knockout of DIS3L impairs the structural integrity of the RNA exosome, thereby providing a powerful model to study exosome-mediated RNA decay mechanisms. The human embryonic kidney origin and the well-characterized transcriptional landscape of HEK293T cells enable precise dissection of how loss of this scaffold protein affects global RNA stability, processing, and surveillance pathways. This model is particularly valuable for investigating the interplay between the exosome and other decay machineries, such as the CCR4-NOT deadenylase complex, in a genetically accessible system.

Researchers can employ this DIS3L knockout polyclonal population to assess changes in transcriptome-wide RNA abundance via RNA-seq, validate specific mRNA targets by RT-qPCR or Northern blotting, and monitor protein expression of downstream effectors through western blotting. Functional studies may include proliferation and apoptosis assays to explore the cellular consequences of altered RNA homeostasis, with potential implications for understanding the role of exosome dysfunction in cancer biology. For additional information, pricing, or technical inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)